|
Patient
|
Antinuclear antibody
|
Rheumatoid factor
|
Thyroglobulin antibody
|
|---|
|
Day 0 (before)
|
Day 36 (during)
|
Day 57 (after)
|
Day 0 (before)
|
Day 36 (during)
|
Day 57 (after)
|
Day 0 (before)
|
Day 36 (during)
|
Day 57 (after)
|
|---|
|
1
|
1:40
|
1:40
|
1:40
|
<20
|
<20
|
<20
|
1:40
|
1:40
|
1:40
|
|
2
|
1:40
|
offa
|
off
|
<20
|
off
|
off
|
1.7
|
off
|
off
|
|
3
|
1:40
|
1:40
|
1:40
|
<20
|
<20
|
<20
|
1:40
|
6.21
|
1:40
|
|
4
|
1:40
|
1:80
|
off
|
<20
|
<20
|
off
|
1:40
|
1:40
|
off
|
|
5
|
(−)
|
(−)
|
(−)b
|
<20
|
22.9
|
23.3
|
1:80
|
1:80
|
<1:10
|
|
6
|
(−)
|
(−)
|
(−)
|
<20
|
<20
|
<20
|
1:80
|
<1:10
|
<1:10
|
|
7
|
(−)
|
(−)
|
(−)
|
<20
|
<20
|
<20
|
1:40
|
1:80
|
1:40
|
|
8
|
(−)
|
(−)
|
off
|
<20
|
<20
|
off
|
1:80
|
1:40
|
off
|
|
9
|
(−)
|
(−)
|
(−)
|
60.6
|
59.5
|
44.2
|
1:160
|
1:80
|
<1:10
|
|
10
|
1:640
|
1:>1280
|
1:>1280
|
<20
|
20.5
|
21.4
|
1:40
|
<1:10
|
1:40
|
|
11
|
1:40
|
1:40
|
1:40
|
<20
|
<20
|
<20
|
5.11
|
3.09
|
7.81
|
|
12
|
1:40
|
1:40
|
1:40
|
<20
|
<20
|
<20
|
14.2
|
0.71
|
1.14
|
- “off” indicates samples were not available for analysis due to withdraw or termination of enrolled patients from this study
-
a“off” indicates samples not available for analysis because of withdrawal or termination of enrolled patients from this study
-
b(−): not detected
